Issues & Experts >
Issues & Experts Archive > World Aids Day: Dec. 1
World Aids Day: Dec. 1
Document Tools
November 24, 2010
Several Simon Fraser University health sciences researchers are standing by to offer context and commentary on the theme of World AIDS Day 2010: Universal Access and Human Rights.
Mark Brockman is a molecular biologist and co-leader of a new $1.8 million project aimed at helping limited research facilities in Africa carry-out much needed HIV research trials, by providing training, equipment and support. He can also comment on biomedical research and vaccine strategies for HIV.
Mark Brockman, mark_brockman@sfu.ca, 778.782.3341 (not available Dec. 1 between 10 a.m. and 12 noon.)
Angela Kaida holds a Canada Research Chair in Global Perspectives in HIV, and Sexual and Reproductive Health. She is looking at how expanding access to HIV treatment services influences reproductive decision-making, behaviours and outcomes among women in high-risk areas—primarily sub-Saharan Africa.
Angela Kaida, kangela@sfu.ca, 778.782.9068
Cari Miller’s work focuses on young people and HIV. She is currently involved in projects locally as well as a project in Soweto, South Africa.
Cari Miller, cari_miller@sfu.ca, 778.782.8652
Jamie Scott works on HIV vaccines. She is investigating the HIV epidemic among injection drug users in Saskatchewan to see if it might be feasible to make a vaccine against the strain of HIV circulating in that particular epidemic.
Jamie Scott, jkscott@sfu.ca, 778.782.5658
Robert Hogg studies how anti-retrovirals can be used to prolong lives and raise resistance levels in people affected with HIV/AIDS. Hogg is head of a network aimed at improving treatment in Canada. Over a five year period (starting in 2009) the Canadian Observational Cohort will track 5,000 people who started on antiretroviral medication in 2000.
Robert Hogg, rhogg@sfu.ca, 778.782.7629
Mark Brockman is a molecular biologist and co-leader of a new $1.8 million project aimed at helping limited research facilities in Africa carry-out much needed HIV research trials, by providing training, equipment and support. He can also comment on biomedical research and vaccine strategies for HIV.
Mark Brockman, mark_brockman@sfu.ca, 778.782.3341 (not available Dec. 1 between 10 a.m. and 12 noon.)
Angela Kaida holds a Canada Research Chair in Global Perspectives in HIV, and Sexual and Reproductive Health. She is looking at how expanding access to HIV treatment services influences reproductive decision-making, behaviours and outcomes among women in high-risk areas—primarily sub-Saharan Africa.
Angela Kaida, kangela@sfu.ca, 778.782.9068
Cari Miller’s work focuses on young people and HIV. She is currently involved in projects locally as well as a project in Soweto, South Africa.
Cari Miller, cari_miller@sfu.ca, 778.782.8652
Jamie Scott works on HIV vaccines. She is investigating the HIV epidemic among injection drug users in Saskatchewan to see if it might be feasible to make a vaccine against the strain of HIV circulating in that particular epidemic.
Jamie Scott, jkscott@sfu.ca, 778.782.5658
Robert Hogg studies how anti-retrovirals can be used to prolong lives and raise resistance levels in people affected with HIV/AIDS. Hogg is head of a network aimed at improving treatment in Canada. Over a five year period (starting in 2009) the Canadian Observational Cohort will track 5,000 people who started on antiretroviral medication in 2000.
Robert Hogg, rhogg@sfu.ca, 778.782.7629